Global Personalized Cancer Medicine Market Research Report 2026(Status and Outlook)
Personalized cancer medicine, also known as targeted therapies or precision medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient"s cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient"s tumor.Immunotherapies: While not traditional targeted therapies, immunotherapies like immune checkpoint inhibitors are another form of personalized cancer treatment. These drugs enhance the patient"s immune system to recognize and attack cancer cells, and they can be tailored to patients based on their tumor"s molecular characteristics.Personalized cancer treatment drugs have revolutionized cancer care by allowing oncologists to tailor treatment plans to the individual characteristics of each patient"s cancer. This approach holds great promise for improving outcomes and reducing the side effects associated with traditional cancer treatments. However, ongoing research and advancements are needed to expand the repertoire of targeted therapies and ensure that they are accessible to more cancer patients.In the global market, the core manufacturers of Precision Cancer Medicine (Personalised Cancer Medicine) are AbbVie, Johnson & Johnson, Novartis, and others. The top three players within this industry account for about 30% of the market share. North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share. The product can be classified on the basis of treatment into immunotherapy and targeted therapy drugs. The product is widely used in the treatment of lung, breast, prostate, blood and other cancers.
The global Personalized Cancer Medicine market size was estimated at USD 192390.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Personalized Cancer Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Personalized Cancer Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Personalized Cancer Medicine market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Cancer Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Personalized Cancer Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Personalized Cancer Medicine market size was estimated at USD 192390.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Personalized Cancer Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Personalized Cancer Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Personalized Cancer Medicine market.
Global Personalized Cancer Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- GSK
- Exelixis
- Regeneron
- Innovent
- Hengrui Medicine
Market Segmentation (by Type)
- Cancer Immunotherapy
- Targeted Therapy
Market Segmentation (by Application)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Blood-related Cancer
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Personalized Cancer Medicine Market
Overview of the regional outlook of the Personalized Cancer Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Cancer Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Personalized Cancer Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Personalized Cancer Medicine
1.2 Key Market Segments
1.2.1 Personalized Cancer Medicine Segment by Type
1.2.2 Personalized Cancer Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERSONALIZED CANCER MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Personalized Cancer Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Personalized Cancer Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERSONALIZED CANCER MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Personalized Cancer Medicine Product Life Cycle
3.3 Global Personalized Cancer Medicine Sales by Manufacturers (2020-2025)
3.4 Global Personalized Cancer Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Personalized Cancer Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Personalized Cancer Medicine Market Competitive Situation and Trends
3.8.1 Personalized Cancer Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Personalized Cancer Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERSONALIZED CANCER MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Personalized Cancer Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERSONALIZED CANCER MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Personalized Cancer Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Personalized Cancer Medicine Market
5.7 ESG Ratings of Leading Companies
6 PERSONALIZED CANCER MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Cancer Medicine Sales Market Share by Type (2020-2025)
6.3 Global Personalized Cancer Medicine Market Size by Type (2020-2025)
6.4 Global Personalized Cancer Medicine Price by Type (2020-2025)
7 PERSONALIZED CANCER MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Cancer Medicine Market Sales by Application (2020-2025)
7.3 Global Personalized Cancer Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Personalized Cancer Medicine Sales Growth Rate by Application (2020-2025)
8 PERSONALIZED CANCER MEDICINE MARKET SALES BY REGION
8.1 Global Personalized Cancer Medicine Sales by Region
8.1.1 Global Personalized Cancer Medicine Sales by Region
8.1.2 Global Personalized Cancer Medicine Sales Market Share by Region
8.2 Global Personalized Cancer Medicine Market Size by Region
8.2.1 Global Personalized Cancer Medicine Market Size by Region
8.2.2 Global Personalized Cancer Medicine Market Size by Region
8.3 North America
8.3.1 North America Personalized Cancer Medicine Sales by Country
8.3.2 North America Personalized Cancer Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Personalized Cancer Medicine Sales by Country
8.4.2 Europe Personalized Cancer Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Personalized Cancer Medicine Sales by Region
8.5.2 Asia Pacific Personalized Cancer Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Personalized Cancer Medicine Sales by Country
8.6.2 South America Personalized Cancer Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Personalized Cancer Medicine Sales by Region
8.7.2 Middle East and Africa Personalized Cancer Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERSONALIZED CANCER MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Personalized Cancer Medicine by Region(2020-2025)
9.2 Global Personalized Cancer Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Personalized Cancer Medicine Production
9.4.1 North America Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.4.2 North America Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Personalized Cancer Medicine Production
9.5.1 Europe Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Personalized Cancer Medicine Production (2020-2025)
9.6.1 Japan Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Personalized Cancer Medicine Production (2020-2025)
9.7.1 China Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.7.2 China Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Personalized Cancer Medicine Product Overview
10.1.3 AbbVie Personalized Cancer Medicine Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Personalized Cancer Medicine Product Overview
10.2.3 Johnson and Johnson Personalized Cancer Medicine Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Novartis
10.3.1 Novartis Basic Information
10.3.2 Novartis Personalized Cancer Medicine Product Overview
10.3.3 Novartis Personalized Cancer Medicine Product Market Performance
10.3.4 Novartis Business Overview
10.3.5 Novartis SWOT Analysis
10.3.6 Novartis Recent Developments
10.4 Gilead Sciences
10.4.1 Gilead Sciences Basic Information
10.4.2 Gilead Sciences Personalized Cancer Medicine Product Overview
10.4.3 Gilead Sciences Personalized Cancer Medicine Product Market Performance
10.4.4 Gilead Sciences Business Overview
10.4.5 Gilead Sciences Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Personalized Cancer Medicine Product Overview
10.5.3 Roche Personalized Cancer Medicine Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Basic Information
10.6.2 Bristol-Myers Squibb Personalized Cancer Medicine Product Overview
10.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Product Market Performance
10.6.4 Bristol-Myers Squibb Business Overview
10.6.5 Bristol-Myers Squibb Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen Personalized Cancer Medicine Product Overview
10.7.3 Amgen Personalized Cancer Medicine Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Basic Information
10.8.2 AstraZeneca Personalized Cancer Medicine Product Overview
10.8.3 AstraZeneca Personalized Cancer Medicine Product Market Performance
10.8.4 AstraZeneca Business Overview
10.8.5 AstraZeneca Recent Developments
10.9 Merck and Co
10.9.1 Merck and Co Basic Information
10.9.2 Merck and Co Personalized Cancer Medicine Product Overview
10.9.3 Merck and Co Personalized Cancer Medicine Product Market Performance
10.9.4 Merck and Co Business Overview
10.9.5 Merck and Co Recent Developments
10.10 Takeda
10.10.1 Takeda Basic Information
10.10.2 Takeda Personalized Cancer Medicine Product Overview
10.10.3 Takeda Personalized Cancer Medicine Product Market Performance
10.10.4 Takeda Business Overview
10.10.5 Takeda Recent Developments
10.11 Merck KGaA
10.11.1 Merck KGaA Basic Information
10.11.2 Merck KGaA Personalized Cancer Medicine Product Overview
10.11.3 Merck KGaA Personalized Cancer Medicine Product Market Performance
10.11.4 Merck KGaA Business Overview
10.11.5 Merck KGaA Recent Developments
10.12 Seagen
10.12.1 Seagen Basic Information
10.12.2 Seagen Personalized Cancer Medicine Product Overview
10.12.3 Seagen Personalized Cancer Medicine Product Market Performance
10.12.4 Seagen Business Overview
10.12.5 Seagen Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Basic Information
10.13.2 Eli Lilly Personalized Cancer Medicine Product Overview
10.13.3 Eli Lilly Personalized Cancer Medicine Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Ono Pharmaceutical
10.14.1 Ono Pharmaceutical Basic Information
10.14.2 Ono Pharmaceutical Personalized Cancer Medicine Product Overview
10.14.3 Ono Pharmaceutical Personalized Cancer Medicine Product Market Performance
10.14.4 Ono Pharmaceutical Business Overview
10.14.5 Ono Pharmaceutical Recent Developments
10.15 Pfizer
10.15.1 Pfizer Basic Information
10.15.2 Pfizer Personalized Cancer Medicine Product Overview
10.15.3 Pfizer Personalized Cancer Medicine Product Market Performance
10.15.4 Pfizer Business Overview
10.15.5 Pfizer Recent Developments
10.16 GSK
10.16.1 GSK Basic Information
10.16.2 GSK Personalized Cancer Medicine Product Overview
10.16.3 GSK Personalized Cancer Medicine Product Market Performance
10.16.4 GSK Business Overview
10.16.5 GSK Recent Developments
10.17 Exelixis
10.17.1 Exelixis Basic Information
10.17.2 Exelixis Personalized Cancer Medicine Product Overview
10.17.3 Exelixis Personalized Cancer Medicine Product Market Performance
10.17.4 Exelixis Business Overview
10.17.5 Exelixis Recent Developments
10.18 Regeneron
10.18.1 Regeneron Basic Information
10.18.2 Regeneron Personalized Cancer Medicine Product Overview
10.18.3 Regeneron Personalized Cancer Medicine Product Market Performance
10.18.4 Regeneron Business Overview
10.18.5 Regeneron Recent Developments
10.19 Innovent
10.19.1 Innovent Basic Information
10.19.2 Innovent Personalized Cancer Medicine Product Overview
10.19.3 Innovent Personalized Cancer Medicine Product Market Performance
10.19.4 Innovent Business Overview
10.19.5 Innovent Recent Developments
10.20 Hengrui Medicine
10.20.1 Hengrui Medicine Basic Information
10.20.2 Hengrui Medicine Personalized Cancer Medicine Product Overview
10.20.3 Hengrui Medicine Personalized Cancer Medicine Product Market Performance
10.20.4 Hengrui Medicine Business Overview
10.20.5 Hengrui Medicine Recent Developments
11 PERSONALIZED CANCER MEDICINE MARKET FORECAST BY REGION
11.1 Global Personalized Cancer Medicine Market Size Forecast
11.2 Global Personalized Cancer Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Personalized Cancer Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Personalized Cancer Medicine Market Size Forecast by Region
11.2.4 South America Personalized Cancer Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Personalized Cancer Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Personalized Cancer Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Personalized Cancer Medicine by Type (2026-2035)
12.1.2 Global Personalized Cancer Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Personalized Cancer Medicine by Type (2026-2035)
12.2 Global Personalized Cancer Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Personalized Cancer Medicine Sales (K MT) Forecast by Application
12.2.2 Global Personalized Cancer Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Personalized Cancer Medicine
1.2 Key Market Segments
1.2.1 Personalized Cancer Medicine Segment by Type
1.2.2 Personalized Cancer Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERSONALIZED CANCER MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Personalized Cancer Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Personalized Cancer Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERSONALIZED CANCER MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Personalized Cancer Medicine Product Life Cycle
3.3 Global Personalized Cancer Medicine Sales by Manufacturers (2020-2025)
3.4 Global Personalized Cancer Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Personalized Cancer Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Personalized Cancer Medicine Market Competitive Situation and Trends
3.8.1 Personalized Cancer Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Personalized Cancer Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERSONALIZED CANCER MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Personalized Cancer Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERSONALIZED CANCER MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Personalized Cancer Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Personalized Cancer Medicine Market
5.7 ESG Ratings of Leading Companies
6 PERSONALIZED CANCER MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Cancer Medicine Sales Market Share by Type (2020-2025)
6.3 Global Personalized Cancer Medicine Market Size by Type (2020-2025)
6.4 Global Personalized Cancer Medicine Price by Type (2020-2025)
7 PERSONALIZED CANCER MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Cancer Medicine Market Sales by Application (2020-2025)
7.3 Global Personalized Cancer Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Personalized Cancer Medicine Sales Growth Rate by Application (2020-2025)
8 PERSONALIZED CANCER MEDICINE MARKET SALES BY REGION
8.1 Global Personalized Cancer Medicine Sales by Region
8.1.1 Global Personalized Cancer Medicine Sales by Region
8.1.2 Global Personalized Cancer Medicine Sales Market Share by Region
8.2 Global Personalized Cancer Medicine Market Size by Region
8.2.1 Global Personalized Cancer Medicine Market Size by Region
8.2.2 Global Personalized Cancer Medicine Market Size by Region
8.3 North America
8.3.1 North America Personalized Cancer Medicine Sales by Country
8.3.2 North America Personalized Cancer Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Personalized Cancer Medicine Sales by Country
8.4.2 Europe Personalized Cancer Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Personalized Cancer Medicine Sales by Region
8.5.2 Asia Pacific Personalized Cancer Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Personalized Cancer Medicine Sales by Country
8.6.2 South America Personalized Cancer Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Personalized Cancer Medicine Sales by Region
8.7.2 Middle East and Africa Personalized Cancer Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERSONALIZED CANCER MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Personalized Cancer Medicine by Region(2020-2025)
9.2 Global Personalized Cancer Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Personalized Cancer Medicine Production
9.4.1 North America Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.4.2 North America Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Personalized Cancer Medicine Production
9.5.1 Europe Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Personalized Cancer Medicine Production (2020-2025)
9.6.1 Japan Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Personalized Cancer Medicine Production (2020-2025)
9.7.1 China Personalized Cancer Medicine Production Growth Rate (2020-2025)
9.7.2 China Personalized Cancer Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Personalized Cancer Medicine Product Overview
10.1.3 AbbVie Personalized Cancer Medicine Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Personalized Cancer Medicine Product Overview
10.2.3 Johnson and Johnson Personalized Cancer Medicine Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Novartis
10.3.1 Novartis Basic Information
10.3.2 Novartis Personalized Cancer Medicine Product Overview
10.3.3 Novartis Personalized Cancer Medicine Product Market Performance
10.3.4 Novartis Business Overview
10.3.5 Novartis SWOT Analysis
10.3.6 Novartis Recent Developments
10.4 Gilead Sciences
10.4.1 Gilead Sciences Basic Information
10.4.2 Gilead Sciences Personalized Cancer Medicine Product Overview
10.4.3 Gilead Sciences Personalized Cancer Medicine Product Market Performance
10.4.4 Gilead Sciences Business Overview
10.4.5 Gilead Sciences Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Personalized Cancer Medicine Product Overview
10.5.3 Roche Personalized Cancer Medicine Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Basic Information
10.6.2 Bristol-Myers Squibb Personalized Cancer Medicine Product Overview
10.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Product Market Performance
10.6.4 Bristol-Myers Squibb Business Overview
10.6.5 Bristol-Myers Squibb Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen Personalized Cancer Medicine Product Overview
10.7.3 Amgen Personalized Cancer Medicine Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Basic Information
10.8.2 AstraZeneca Personalized Cancer Medicine Product Overview
10.8.3 AstraZeneca Personalized Cancer Medicine Product Market Performance
10.8.4 AstraZeneca Business Overview
10.8.5 AstraZeneca Recent Developments
10.9 Merck and Co
10.9.1 Merck and Co Basic Information
10.9.2 Merck and Co Personalized Cancer Medicine Product Overview
10.9.3 Merck and Co Personalized Cancer Medicine Product Market Performance
10.9.4 Merck and Co Business Overview
10.9.5 Merck and Co Recent Developments
10.10 Takeda
10.10.1 Takeda Basic Information
10.10.2 Takeda Personalized Cancer Medicine Product Overview
10.10.3 Takeda Personalized Cancer Medicine Product Market Performance
10.10.4 Takeda Business Overview
10.10.5 Takeda Recent Developments
10.11 Merck KGaA
10.11.1 Merck KGaA Basic Information
10.11.2 Merck KGaA Personalized Cancer Medicine Product Overview
10.11.3 Merck KGaA Personalized Cancer Medicine Product Market Performance
10.11.4 Merck KGaA Business Overview
10.11.5 Merck KGaA Recent Developments
10.12 Seagen
10.12.1 Seagen Basic Information
10.12.2 Seagen Personalized Cancer Medicine Product Overview
10.12.3 Seagen Personalized Cancer Medicine Product Market Performance
10.12.4 Seagen Business Overview
10.12.5 Seagen Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Basic Information
10.13.2 Eli Lilly Personalized Cancer Medicine Product Overview
10.13.3 Eli Lilly Personalized Cancer Medicine Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Ono Pharmaceutical
10.14.1 Ono Pharmaceutical Basic Information
10.14.2 Ono Pharmaceutical Personalized Cancer Medicine Product Overview
10.14.3 Ono Pharmaceutical Personalized Cancer Medicine Product Market Performance
10.14.4 Ono Pharmaceutical Business Overview
10.14.5 Ono Pharmaceutical Recent Developments
10.15 Pfizer
10.15.1 Pfizer Basic Information
10.15.2 Pfizer Personalized Cancer Medicine Product Overview
10.15.3 Pfizer Personalized Cancer Medicine Product Market Performance
10.15.4 Pfizer Business Overview
10.15.5 Pfizer Recent Developments
10.16 GSK
10.16.1 GSK Basic Information
10.16.2 GSK Personalized Cancer Medicine Product Overview
10.16.3 GSK Personalized Cancer Medicine Product Market Performance
10.16.4 GSK Business Overview
10.16.5 GSK Recent Developments
10.17 Exelixis
10.17.1 Exelixis Basic Information
10.17.2 Exelixis Personalized Cancer Medicine Product Overview
10.17.3 Exelixis Personalized Cancer Medicine Product Market Performance
10.17.4 Exelixis Business Overview
10.17.5 Exelixis Recent Developments
10.18 Regeneron
10.18.1 Regeneron Basic Information
10.18.2 Regeneron Personalized Cancer Medicine Product Overview
10.18.3 Regeneron Personalized Cancer Medicine Product Market Performance
10.18.4 Regeneron Business Overview
10.18.5 Regeneron Recent Developments
10.19 Innovent
10.19.1 Innovent Basic Information
10.19.2 Innovent Personalized Cancer Medicine Product Overview
10.19.3 Innovent Personalized Cancer Medicine Product Market Performance
10.19.4 Innovent Business Overview
10.19.5 Innovent Recent Developments
10.20 Hengrui Medicine
10.20.1 Hengrui Medicine Basic Information
10.20.2 Hengrui Medicine Personalized Cancer Medicine Product Overview
10.20.3 Hengrui Medicine Personalized Cancer Medicine Product Market Performance
10.20.4 Hengrui Medicine Business Overview
10.20.5 Hengrui Medicine Recent Developments
11 PERSONALIZED CANCER MEDICINE MARKET FORECAST BY REGION
11.1 Global Personalized Cancer Medicine Market Size Forecast
11.2 Global Personalized Cancer Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Personalized Cancer Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Personalized Cancer Medicine Market Size Forecast by Region
11.2.4 South America Personalized Cancer Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Personalized Cancer Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Personalized Cancer Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Personalized Cancer Medicine by Type (2026-2035)
12.1.2 Global Personalized Cancer Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Personalized Cancer Medicine by Type (2026-2035)
12.2 Global Personalized Cancer Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Personalized Cancer Medicine Sales (K MT) Forecast by Application
12.2.2 Global Personalized Cancer Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Personalized Cancer Medicine Market Size by Type (M USD)
Table 4. Global Personalized Cancer Medicine Market Size by Application
Table 5. Personalized Cancer Medicine Market Size Comparison by Region (M USD)
Table 6. Global Personalized Cancer Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Personalized Cancer Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Personalized Cancer Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Personalized Cancer Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2025)
Table 11. Global Market Personalized Cancer Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Personalized Cancer Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Personalized Cancer Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Personalized Cancer Medicine Sales by Type (K MT)
Table 27. Global Personalized Cancer Medicine Market Size by Type (M USD)
Table 28. Global Personalized Cancer Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Personalized Cancer Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Personalized Cancer Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Personalized Cancer Medicine Market Share by Type (2020-2025)
Table 32. Global Personalized Cancer Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Personalized Cancer Medicine Sales (K MT) by Application
Table 34. Global Personalized Cancer Medicine Market Size by Application
Table 35. Global Personalized Cancer Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Personalized Cancer Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Personalized Cancer Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Personalized Cancer Medicine Market Share by Application (2020-2025)
Table 39. Global Personalized Cancer Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Personalized Cancer Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Personalized Cancer Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Personalized Cancer Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Personalized Cancer Medicine Market Size by Region (2020-2025)
Table 44. North America Personalized Cancer Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Personalized Cancer Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Personalized Cancer Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Personalized Cancer Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Personalized Cancer Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Personalized Cancer Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Personalized Cancer Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Personalized Cancer Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Personalized Cancer Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Personalized Cancer Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Personalized Cancer Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Personalized Cancer Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Personalized Cancer Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. AbbVie Basic Information
Table 63. AbbVie Personalized Cancer Medicine Product Overview
Table 64. AbbVie Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. AbbVie Business Overview
Table 66. AbbVie SWOT Analysis
Table 67. AbbVie Recent Developments
Table 68. Johnson and Johnson Basic Information
Table 69. Johnson and Johnson Personalized Cancer Medicine Product Overview
Table 70. Johnson and Johnson Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson SWOT Analysis
Table 73. Johnson and Johnson Recent Developments
Table 74. Novartis Basic Information
Table 75. Novartis Personalized Cancer Medicine Product Overview
Table 76. Novartis Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Novartis Business Overview
Table 78. Novartis SWOT Analysis
Table 79. Novartis Recent Developments
Table 80. Gilead Sciences Basic Information
Table 81. Gilead Sciences Personalized Cancer Medicine Product Overview
Table 82. Gilead Sciences Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Personalized Cancer Medicine Product Overview
Table 87. Roche Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. Bristol-Myers Squibb Basic Information
Table 91. Bristol-Myers Squibb Personalized Cancer Medicine Product Overview
Table 92. Bristol-Myers Squibb Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Recent Developments
Table 95. Amgen Basic Information
Table 96. Amgen Personalized Cancer Medicine Product Overview
Table 97. Amgen Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Amgen Business Overview
Table 99. Amgen Recent Developments
Table 100. AstraZeneca Basic Information
Table 101. AstraZeneca Personalized Cancer Medicine Product Overview
Table 102. AstraZeneca Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Recent Developments
Table 105. Merck and Co Basic Information
Table 106. Merck and Co Personalized Cancer Medicine Product Overview
Table 107. Merck and Co Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Merck and Co Business Overview
Table 109. Merck and Co Recent Developments
Table 110. Takeda Basic Information
Table 111. Takeda Personalized Cancer Medicine Product Overview
Table 112. Takeda Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Takeda Business Overview
Table 114. Takeda Recent Developments
Table 115. Merck KGaA Basic Information
Table 116. Merck KGaA Personalized Cancer Medicine Product Overview
Table 117. Merck KGaA Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck KGaA Business Overview
Table 119. Merck KGaA Recent Developments
Table 120. Seagen Basic Information
Table 121. Seagen Personalized Cancer Medicine Product Overview
Table 122. Seagen Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Seagen Business Overview
Table 124. Seagen Recent Developments
Table 125. Eli Lilly Basic Information
Table 126. Eli Lilly Personalized Cancer Medicine Product Overview
Table 127. Eli Lilly Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Recent Developments
Table 130. Ono Pharmaceutical Basic Information
Table 131. Ono Pharmaceutical Personalized Cancer Medicine Product Overview
Table 132. Ono Pharmaceutical Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Ono Pharmaceutical Business Overview
Table 134. Ono Pharmaceutical Recent Developments
Table 135. Pfizer Basic Information
Table 136. Pfizer Personalized Cancer Medicine Product Overview
Table 137. Pfizer Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Pfizer Business Overview
Table 139. Pfizer Recent Developments
Table 140. GSK Basic Information
Table 141. GSK Personalized Cancer Medicine Product Overview
Table 142. GSK Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. GSK Business Overview
Table 144. GSK Recent Developments
Table 145. Exelixis Basic Information
Table 146. Exelixis Personalized Cancer Medicine Product Overview
Table 147. Exelixis Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Exelixis Business Overview
Table 149. Exelixis Recent Developments
Table 150. Regeneron Basic Information
Table 151. Regeneron Personalized Cancer Medicine Product Overview
Table 152. Regeneron Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Regeneron Business Overview
Table 154. Regeneron Recent Developments
Table 155. Innovent Basic Information
Table 156. Innovent Personalized Cancer Medicine Product Overview
Table 157. Innovent Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Innovent Business Overview
Table 159. Innovent Recent Developments
Table 160. Hengrui Medicine Basic Information
Table 161. Hengrui Medicine Personalized Cancer Medicine Product Overview
Table 162. Hengrui Medicine Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Hengrui Medicine Business Overview
Table 164. Hengrui Medicine Recent Developments
Table 165. Global Personalized Cancer Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Personalized Cancer Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Personalized Cancer Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Personalized Cancer Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Personalized Cancer Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Personalized Cancer Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Personalized Cancer Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Personalized Cancer Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Personalized Cancer Medicine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Personalized Cancer Medicine Market Size by Type (M USD)
Table 4. Global Personalized Cancer Medicine Market Size by Application
Table 5. Personalized Cancer Medicine Market Size Comparison by Region (M USD)
Table 6. Global Personalized Cancer Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Personalized Cancer Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Personalized Cancer Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Personalized Cancer Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2025)
Table 11. Global Market Personalized Cancer Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Personalized Cancer Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Personalized Cancer Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Personalized Cancer Medicine Sales by Type (K MT)
Table 27. Global Personalized Cancer Medicine Market Size by Type (M USD)
Table 28. Global Personalized Cancer Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Personalized Cancer Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Personalized Cancer Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Personalized Cancer Medicine Market Share by Type (2020-2025)
Table 32. Global Personalized Cancer Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Personalized Cancer Medicine Sales (K MT) by Application
Table 34. Global Personalized Cancer Medicine Market Size by Application
Table 35. Global Personalized Cancer Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Personalized Cancer Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Personalized Cancer Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Personalized Cancer Medicine Market Share by Application (2020-2025)
Table 39. Global Personalized Cancer Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Personalized Cancer Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Personalized Cancer Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Personalized Cancer Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Personalized Cancer Medicine Market Size by Region (2020-2025)
Table 44. North America Personalized Cancer Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Personalized Cancer Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Personalized Cancer Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Personalized Cancer Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Personalized Cancer Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Personalized Cancer Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Personalized Cancer Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Personalized Cancer Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Personalized Cancer Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Personalized Cancer Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Personalized Cancer Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Personalized Cancer Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Personalized Cancer Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Personalized Cancer Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. AbbVie Basic Information
Table 63. AbbVie Personalized Cancer Medicine Product Overview
Table 64. AbbVie Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. AbbVie Business Overview
Table 66. AbbVie SWOT Analysis
Table 67. AbbVie Recent Developments
Table 68. Johnson and Johnson Basic Information
Table 69. Johnson and Johnson Personalized Cancer Medicine Product Overview
Table 70. Johnson and Johnson Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson SWOT Analysis
Table 73. Johnson and Johnson Recent Developments
Table 74. Novartis Basic Information
Table 75. Novartis Personalized Cancer Medicine Product Overview
Table 76. Novartis Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Novartis Business Overview
Table 78. Novartis SWOT Analysis
Table 79. Novartis Recent Developments
Table 80. Gilead Sciences Basic Information
Table 81. Gilead Sciences Personalized Cancer Medicine Product Overview
Table 82. Gilead Sciences Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Personalized Cancer Medicine Product Overview
Table 87. Roche Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. Bristol-Myers Squibb Basic Information
Table 91. Bristol-Myers Squibb Personalized Cancer Medicine Product Overview
Table 92. Bristol-Myers Squibb Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Recent Developments
Table 95. Amgen Basic Information
Table 96. Amgen Personalized Cancer Medicine Product Overview
Table 97. Amgen Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Amgen Business Overview
Table 99. Amgen Recent Developments
Table 100. AstraZeneca Basic Information
Table 101. AstraZeneca Personalized Cancer Medicine Product Overview
Table 102. AstraZeneca Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Recent Developments
Table 105. Merck and Co Basic Information
Table 106. Merck and Co Personalized Cancer Medicine Product Overview
Table 107. Merck and Co Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Merck and Co Business Overview
Table 109. Merck and Co Recent Developments
Table 110. Takeda Basic Information
Table 111. Takeda Personalized Cancer Medicine Product Overview
Table 112. Takeda Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Takeda Business Overview
Table 114. Takeda Recent Developments
Table 115. Merck KGaA Basic Information
Table 116. Merck KGaA Personalized Cancer Medicine Product Overview
Table 117. Merck KGaA Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck KGaA Business Overview
Table 119. Merck KGaA Recent Developments
Table 120. Seagen Basic Information
Table 121. Seagen Personalized Cancer Medicine Product Overview
Table 122. Seagen Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Seagen Business Overview
Table 124. Seagen Recent Developments
Table 125. Eli Lilly Basic Information
Table 126. Eli Lilly Personalized Cancer Medicine Product Overview
Table 127. Eli Lilly Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Recent Developments
Table 130. Ono Pharmaceutical Basic Information
Table 131. Ono Pharmaceutical Personalized Cancer Medicine Product Overview
Table 132. Ono Pharmaceutical Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Ono Pharmaceutical Business Overview
Table 134. Ono Pharmaceutical Recent Developments
Table 135. Pfizer Basic Information
Table 136. Pfizer Personalized Cancer Medicine Product Overview
Table 137. Pfizer Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Pfizer Business Overview
Table 139. Pfizer Recent Developments
Table 140. GSK Basic Information
Table 141. GSK Personalized Cancer Medicine Product Overview
Table 142. GSK Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. GSK Business Overview
Table 144. GSK Recent Developments
Table 145. Exelixis Basic Information
Table 146. Exelixis Personalized Cancer Medicine Product Overview
Table 147. Exelixis Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Exelixis Business Overview
Table 149. Exelixis Recent Developments
Table 150. Regeneron Basic Information
Table 151. Regeneron Personalized Cancer Medicine Product Overview
Table 152. Regeneron Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Regeneron Business Overview
Table 154. Regeneron Recent Developments
Table 155. Innovent Basic Information
Table 156. Innovent Personalized Cancer Medicine Product Overview
Table 157. Innovent Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Innovent Business Overview
Table 159. Innovent Recent Developments
Table 160. Hengrui Medicine Basic Information
Table 161. Hengrui Medicine Personalized Cancer Medicine Product Overview
Table 162. Hengrui Medicine Personalized Cancer Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Hengrui Medicine Business Overview
Table 164. Hengrui Medicine Recent Developments
Table 165. Global Personalized Cancer Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Personalized Cancer Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Personalized Cancer Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Personalized Cancer Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Personalized Cancer Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Personalized Cancer Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Personalized Cancer Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Personalized Cancer Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Personalized Cancer Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Personalized Cancer Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Personalized Cancer Medicine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Personalized Cancer Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Cancer Medicine Market Size (M USD), 2025-2035
Figure 5. Global Personalized Cancer Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Personalized Cancer Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Personalized Cancer Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Personalized Cancer Medicine Product Life Cycle
Figure 13. Personalized Cancer Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Personalized Cancer Medicine Revenue Share by Manufacturers in 2025
Figure 15. Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Personalized Cancer Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Personalized Cancer Medicine Revenue in 2025
Figure 18. Industry Chain Map of Personalized Cancer Medicine
Figure 19. Global Personalized Cancer Medicine Market PEST Analysis
Figure 20. Global Personalized Cancer Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Personalized Cancer Medicine Market Share by Type
Figure 27. Sales Market Share of Personalized Cancer Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Personalized Cancer Medicine by Type in 2025
Figure 29. Market Share of Personalized Cancer Medicine by Type (2020-2025)
Figure 30. Market Share of Personalized Cancer Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Personalized Cancer Medicine Market Share by Application
Figure 33. Global Personalized Cancer Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Personalized Cancer Medicine Sales Market Share by Application in 2025
Figure 35. Global Personalized Cancer Medicine Market Share by Application (2020-2025)
Figure 36. Global Personalized Cancer Medicine Market Share by Application in 2025
Figure 37. Global Personalized Cancer Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Personalized Cancer Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Personalized Cancer Medicine Market Size by Region (2020-2025)
Figure 40. North America Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Personalized Cancer Medicine Sales Market Share by Country in 2024
Figure 43. North America Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Personalized Cancer Medicine Market Size by Country in 2024
Figure 45. U.S. Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Personalized Cancer Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Personalized Cancer Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Personalized Cancer Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Personalized Cancer Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Personalized Cancer Medicine Sales Market Share by Country in 2024
Figure 53. Europe Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Personalized Cancer Medicine Market Size by Country in 2024
Figure 55. Germany Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Personalized Cancer Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Personalized Cancer Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Personalized Cancer Medicine Market Size by Region in 2024
Figure 68. China Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Personalized Cancer Medicine Sales and Growth Rate (K MT)
Figure 79. South America Personalized Cancer Medicine Sales Market Share by Country in 2024
Figure 80. South America Personalized Cancer Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Personalized Cancer Medicine Market Size by Country in 2024
Figure 82. Brazil Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Personalized Cancer Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Personalized Cancer Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Personalized Cancer Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Personalized Cancer Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Personalized Cancer Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Personalized Cancer Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Personalized Cancer Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Personalized Cancer Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Personalized Cancer Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Personalized Cancer Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Personalized Cancer Medicine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Personalized Cancer Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Cancer Medicine Market Size (M USD), 2025-2035
Figure 5. Global Personalized Cancer Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Personalized Cancer Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Personalized Cancer Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Personalized Cancer Medicine Product Life Cycle
Figure 13. Personalized Cancer Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Personalized Cancer Medicine Revenue Share by Manufacturers in 2025
Figure 15. Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Personalized Cancer Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Personalized Cancer Medicine Revenue in 2025
Figure 18. Industry Chain Map of Personalized Cancer Medicine
Figure 19. Global Personalized Cancer Medicine Market PEST Analysis
Figure 20. Global Personalized Cancer Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Personalized Cancer Medicine Market Share by Type
Figure 27. Sales Market Share of Personalized Cancer Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Personalized Cancer Medicine by Type in 2025
Figure 29. Market Share of Personalized Cancer Medicine by Type (2020-2025)
Figure 30. Market Share of Personalized Cancer Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Personalized Cancer Medicine Market Share by Application
Figure 33. Global Personalized Cancer Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Personalized Cancer Medicine Sales Market Share by Application in 2025
Figure 35. Global Personalized Cancer Medicine Market Share by Application (2020-2025)
Figure 36. Global Personalized Cancer Medicine Market Share by Application in 2025
Figure 37. Global Personalized Cancer Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Personalized Cancer Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Personalized Cancer Medicine Market Size by Region (2020-2025)
Figure 40. North America Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Personalized Cancer Medicine Sales Market Share by Country in 2024
Figure 43. North America Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Personalized Cancer Medicine Market Size by Country in 2024
Figure 45. U.S. Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Personalized Cancer Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Personalized Cancer Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Personalized Cancer Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Personalized Cancer Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Personalized Cancer Medicine Sales Market Share by Country in 2024
Figure 53. Europe Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Personalized Cancer Medicine Market Size by Country in 2024
Figure 55. Germany Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Personalized Cancer Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Personalized Cancer Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Personalized Cancer Medicine Market Size by Region in 2024
Figure 68. China Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Personalized Cancer Medicine Sales and Growth Rate (K MT)
Figure 79. South America Personalized Cancer Medicine Sales Market Share by Country in 2024
Figure 80. South America Personalized Cancer Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Personalized Cancer Medicine Market Size by Country in 2024
Figure 82. Brazil Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Personalized Cancer Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Personalized Cancer Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Personalized Cancer Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Personalized Cancer Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Personalized Cancer Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Personalized Cancer Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Personalized Cancer Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Personalized Cancer Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Personalized Cancer Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Personalized Cancer Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Personalized Cancer Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Personalized Cancer Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Personalized Cancer Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Personalized Cancer Medicine Market Share Forecast by Application (2026-2035)